Study reveals weight loss medications may improve outcomes for chronic sinus disease patients

A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists (GLP-1RAs)—a class of medications primarily used for weight loss and diabetes management—may significantly improve post-surgical outcomes for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and obesity.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup